Photoimmunotherapy for cancer treatment

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 25, Issue 1-2, 2006, Pages 281-291

  Chen, Wei R ^a   Huang, Zheng ^b   Korbelik, Mladen ^c   Nordquist, Robert E ^d   Liu, Hong ^e  

^a UNIVERSITY OF CENTRAL OKLAHOMA   (United States)

^b Highlands Presbyterian St Luke's Podiatric Medicine and Surgery Residency Program   (United States)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d Wound Healing of Oklahoma Inc   (United States)

^e University of Oklahoma   (United States)

Author keywords

Immunoadjuvants; Immunotherapy; Induced antitumor immunity; Photodynamic therapy; Selective photothermal therapy

Indexed keywords

BCG VACCINE; GLYCATED CHITOSAN; IMMUNOLOGICAL ADJUVANT; INDOCYANINE GREEN; METATETRAHYDROXYPHENYLCHLORIN; PHOTOFRIN; RADIOSENSITIZING AGENT; SCHIZOPHYLLAN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER IMMUNOTHERAPY; CANCER THERAPY; CELLULAR IMMUNITY; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LONG TERM CARE; LUNG TUMOR; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME;

ANIMALIA;

EID: 33644773755     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v25.i1-2.180     Document Type: Article

References (66)

1. Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Peng Q. Photodynamic therapy. J Natl Cancer Inst 1998; 90:889-905.
2. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle DG, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978; 38:2628-2635.
3. Dougherty TJ. Photoradiation therapy for cutaneous and subcutaneous malignancies. J Invest Dermatol 1981; 77:122-124.
4. Dougherty TJ. Photodynamic therapy: status and potential. Oncology 1989; 3:67-78.
5. Fisher L, Murphee AL, Gomer CJ. Clinical and pre-clinical photodynamic therapy. Lasers Surg Med 1995; 17:2-31.
6. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photodynamic inactivation of a murine tumor. Cancer Res 1979; 36:2326-2329.
7. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992; 55:145-157.
8. Chaudhuri K. Morphological changes in tumor microvasculature following hematoporphyrin derivative sensitized photodynamic therapy. Photochem Photobiol 1987; 46:823-827.
9. Nelson J. Tumor destruction in photodynamic therapy. Photochem Photobiol 1987; 46:829-835.
10. Pass H.I. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993; 85:443-456.
11. Chen WR, Adams RL, Heaton S, Dickey DT, Bartels KE, Nordquist RE. Chromophore-enhanced laser-tumor tissue photothermal interaction using 808 nm diode laser. Cancer Lett 1995; 88:15-19.
12. Chen WR, Adams RL, Bartels KE, Nordquist RE. Chromophore-enhanced in vivo tumor cell destruction using an 808-nm diode laser. Cancer Lett, 1995; 94:125-131.
13. Chen WR, Adams RL, Higgins AK, Bartels KE, Nordquist RE. Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: An in vivo efficacy study. Cancer Lett 1996; 98:169-173.
14. Liotta LA, Stetler-Stevenson WG. Principles of molecular cell biology of cancer: cancer metastasis. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles & Practice of Oncology. Philadelphia: Lippincott, 1993; 134-149.
15. Clark WH, Jr., Elder DE, Guerry DIV, Braitman LE, Trock BJ, Schultz D, Synnestevdt M, Halpern AC. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81:1893-1904.
16. O'Reilly M, Rosenthal R, Sage EH, Smith S, Holmgren L, Moses M, Shing Y, Folkman J. The suppression of tumor metastases by a primary tumor. Surg Forum 1993; 44:474-476.
17. Camphausen K, Moses MA, Beecken W-D, Khan MK, Folkman J, O'Reilly MS. Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 2001; 61:2207-11.
18. Anghileri LJ, Robert J. Hyperthermia in Cancer Treatment. Boca Raton: CRC Press, 1986.
19. Oleinick NL, Evans HH. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 1998; 150:S146-S156.
20. Wyld L, Reed MW, Brown NJ. Differential cell death response to photodynamic therapy is dependent on dose and cell type. Br J Cancer 2001; 84:1384-1386.
21. Huang Z, Chen Q, Luck D, Beckers J, Wilson BC, Trncic N, LaRue SM, Blanc D, Hetzel FW. Studies of a vascular-acting photosensitizer, Pd- bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer. Lasers Surg Med 2005; 36:390-397.
22. Lynch DH, Haddad S, Vernon KJ, Ott MJ, Straight RC, Jolles CJ. Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophages. Photochem Photobiol 1989; 49:453-458.
23. Musser DA, Fiel RJ. Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins. Photochem Photobiol 1991; 53:119-123.
24. Gomer CJ, Ferrario A, Hayashi N, Rucher N, Szirth BC, Murphree AL. Molecular, cellular, and tissue responses following photodynamic therapy. Lasers Surgy Med 1988; 8:450-463.
25. Elmets CA, Bowen KD. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Resh 1986; 46:1608-1611.
26. Jolles CJ, Ott MJ, Straight RC, Lynch DH. Systemic immunosuppression induced by peritoneal photodynamic therapy. Am J Obstet Gynecol 1988; 158:1446-1453.
27. Reddan JC, Anderson CY, Xu H, Hrabovsky S, Freye K, Fairchild R, Tubesing KA, Elmets CA. Immunosuppressive effects of silicon phthalocyanine photodynamic therapy. Photochem Photobiol 1999; 70:72-77.
28. van Duijnhoven FH, Aalbers RIJM, Rovers JP, Terpstra OT, Kuppen PJK. The immunological consequences of photodynamic treatment of cancer, a literature review. Immunobiology 2003; 207:105-113.
29. Yamamoto N, Hoober JK, Yamamoto N, Yamamoto S. Tumoricidal capacities of macrophages photodynamically activated with hematoporphyrin derivative. Photochem Photobiol 1992; 56:245-250.
30. Korbelik M, Krosl G. Enhanced macrophage cytotoxicity against tumor cells treated with photodynamic therapy. Photochem Photobiol 1994; 60:497-502.
31. Krosl G, Korbelik M, Dougherty GJ. Induction of immune cell infiltration into murine SCCVII tumor by Photofrin based photodynamic therapy. Br J Cancer 1995; 71:549-555.
32. Krosl G, Korbelik M, Krosl J, Dougherty GJ. Potentiation of photodynamic therapy-elicited antitumor response by localized treatment with granulocyte-macrophage colony-stimulating factor. Cancer Res 1996; 56:3281-3286.
33. Canti G, Lattuada D, Nicolin A, Taroni P, Valentini G, Cubeddu R. Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light. Anticancer Drugs 1994; 5:443-447.
34. Ryter SW, Gomer CJ. Nuclear factor kappa B binding activity in mouse L1210 cells following photofrin II-mediated photosensitization. Photochem Photobiol 1993; 58:753-756.
35. Kick G, Messer G, Goetz A, Plewig G, Kind P. Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res 1995; 55:2373-2379.
36. Gollnick SO, Lee BY, Vaughan L, Owczarczak B, Henderson BW. Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes. Photochem Photobiol 2001; 73:170-177.
37. Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res 2005; 65:1018-1026.
38. Korbelik M. Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg 1996; 14:329-334.
39. Gollnick SO, Evans SS, Baumann H, Owczarczak B, Maier P, Vaughan L, Wang WC, Unger E, Henderson BW. Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br J Cancer 2003; 88:1772-1779.
40. Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson IN. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 2001; 61:192-196.
41. Korbelik M, Sun J, Cecic I, Serrano K. Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors. Photochem Photobiol Sci 2004; 3:812-816.
42. Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 2002; 62:1604-1608.
43. Krosl G, Korbelik M. Potentiation of photodynamic therapy by immunotherapy: the effect of schizophyllan (SPG). Cancer Lett 1994; 84:43-49.
44. Korbelik M, Naraparaju VR, Yamamoto N. Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer. Br J Cancer 1997; 75:202-207.
45. Myers RC, Lau BH, Kunihira DY, Torrey RR, Woolley JL, Tosk J. Modulation of hematoporphyrin derivative-sensitized phototherapy with corynebacterium parvum in murine transitional cell carcinoma. Urology 1989; 33(3):230-235.
46. Cho YH, Straight RC, Smith JA Jr. Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model. J Urol 1992; 147(3):743-746.
47. Chen WR, Carubelli R, Liu H, Nordquist RE. Laser immunotherapy: a novel treatment modality for metastatic tumors. Mol Biotechnol 2003; 25:37-43.
48. Chen WR, Adams RL, Nordquist RE. Laser-photosensitizer assisted immunotherapy: A novel modality in cancer treatment. Cancer Lett 1997; 115:25-30.
49. Chen WR, Korbelik M, Bartels KE, Liu H, Sun J, Nordquist RE. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant. Photochem Photobiol 2005; 81:190-195.
50. Rockwell SC, Kallman RF, Fajardo LF. Characteristics of a serially transplanted mouse mammary tumour and its tissue-culture-adapted derivative. J Natl Cancer Inst 1972; 49:735-749.
51. Yuhas JM, Pazmino NH, Proctor JO, Toya RE. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor. Cancer Res 1974; 34:722-728.
52. Song CW, Lokshina A, Rhee JG, Patten M, Levitt SH. Implication of blood flow in hyperthermic treatment of tumors. IEEE Trans Biomed Eng 1984; 31:9-16.
53. Reinhold HS, Endrich B. Tumor microcirculation as a target for hyperthermia: A review. Int J Hyperthermia 1986; 2:111-137.
54. Thistlethwaite AJ, Leeper DB, Moylan DJ, Nerlinger RE. pH distribution in human tumors. Int J Radiat Oncol Biol Phys 1986; 11:1647-1652.
55. Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. Cellular responses to combinations of hyperthermia and radiation. Radiology 1977; 123:463-474.
56. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10:787-800.
57. Dewhirst MW, Conner WG, Moon TE, Roth HB. Response of spontaneous animal tumors to heat and/or radiation: preliminary results of a phase III trial. J Natl Cancer Inst 1982; 61:395-397.
58. Manning MR, Cetas TC, Miller RC, Oleson JR, Conner WG, Gerner EW. Results of a phase I trial employing hyperthermia alone or in combination with external beam or interstitial radiotherapy. Cancer 1982; 49:205-216.
59. Lucroy MD, Chen WR, Ridgway TD, Higbee RG, Bartels KE. Selective laser-induced hyperthermia for the treatment of spontaneous tumors in dogs. J X-Ray Sci Tech 2002; 10:237-243.
60. Chatterjee SK, Kim U. Fucosyltransferase activity in metastasizing and nonmetastasizing rat mammary carcinomas. J Natl Cancer Inst 1978; 61:151-162.
61. Chen WR, Zhu W-G, Dynlacht JR, Liu H, Nordquist RE. Long-term tumor resistance induced by laser photo-immunotherapy. Intnl J Cancer 1999; 81:808-812.
62. Chen WR, Liu H, Nordquist JA, Nordquist RE. Tumor cell damage and leukocyte infiltration after laser immunotherapy treatment. Lasers Med Sci 2000; 15:43-48.
63. Chen WR, Singhal AK, Liu H, Nordquist RE. Laser immunotherapy induced antitumor immunity and its adoptive transfer. Cancer Res 2001; 61:459-461.
64. Chen WR, Liu H, Ritchey JE, Bartels KE, Lucroy MD, Nordquist RE. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Cancer Res 2002; 62:4295-4299.
65. Chen WR, Carubelli R, Liu H, Nordquist RE. Detection of anti-tumor immunity induced by laser immunotherapy. Mol Biotechnol 2003; 25:45-51.
66. Chen WR, Jeong SW, Lucroy MD, Wolf RF, Liu H, Nordquist RE. Induced anti-tumor immunity against DMBA-4 metastatic mammary tumors in rats using a novel approach. Intl J Cancer 2003; 107:1053-1057.